Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus

Gastroenterology

Volumn 122, Issue 2, 2002, Pages 299-307

  Souza, Rhonda F ^a,b   Shewmake, Kenneth ^a   Terada, Lance S ^a   Spechler, Stuart Jon ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HYDROCHLORIC ACID; MITOGEN ACTIVATED PROTEIN KINASE;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0036161377     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.30993     Document Type: Article

References (27)

1. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
2. Barrett's esophagus
3. Ornithine decarboxylase activity in Barrett's esophagus: A potential marker for dysplasia
4. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus
5. Reflux-induced apoptosis of the esophageal mucosa is inhibited in Barrett's epithelium
6. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: A comparative study
7. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model
8. Altered sodiumhydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus
9. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
10. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
11. Functional foregut abnormalities in Barrett's esophagus
12. Concentration of refluxed acid and esophageal mucosal injury
13. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways
14. The regulation of AP-1 activity by mitogen-activated protein kinases
15. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
16. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells
17. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender
18. Cytosolic alkalinization increases stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) activity and p38 mitogen-activated protein kinase activity by a calcium-independent mechanism
19. AP-1: One switch for many signals
20. Fas ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogenactivated protein kinase: Regulators of distinct cell death and survival pathways in granulocytes
21. Low extracellular pH induces activation of ERK 2, JNK, and p38 in A431 and Swiss 3T3 cells
22. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites
23. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis
24. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells
25. Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells
26. Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells
27. Suppression of PMN apoptosis by hypoxia is dependent on Mcl-1 and MAPK activity